Skip to main content
Log in

Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

NK4 is a variant form of HGF/SF, comprising the N-terminal and subsequent four kringle domains of mature HGF/SF. HGF/SF is a multifunctional cytokine that enhances the metastatic behaviour of tumour cells in vitro by stimulation of the c-met receptor tyrosine kinase and has been implicated in the development of tumour metastasis in vivo. The aims of this study were to further investigate the potential antagonistic effects of the recently described variant form of HGF/SF, NK4, on HGF/SF activity in breast cancer cells. All cell lines used expressed both the HGF/SF receptor gene and protein as shown by RT-PCR and Western blotting. NK4 inhibited HGF/SF-induced tumour cell invasion through an artificial basement membrane. Tumour cell motility and scattering induced by HGF/SF were also dramatically reduced by the inclusion of NK4. Immunoprecipitation studies revealed that NK4 inhibited the phosphorylation of the c-met receptor in response to HGF/SF. Treatment of these cells with NK4 alone did not have any significant effects on their metastatic behaviour. From this data we conclude that NK4 demonstrates significant antagonistic properties towards HGF/SF, inhibiting HGF/SF-stimulated breast tumour cell invasion, motility and migration. NK4 may therefore be of potential benefit in the development of anti-metastasis therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stracke ML, Liotta LA: In: Mendelson J, Howley PM, Israel MA, Liotta LA (eds) The Molecular Basis of Cancer. WB Saunders Company, Philadelphia, 1995, pp 233–247.

    Google Scholar 

  2. Hart IR, Goode NT, Wilson RE: Molecular aspects of the metastatic cascade. Biochim Biophys Acta 989: 65–84, 1989

    Google Scholar 

  3. Hu M, Pollock RE, Nakamura T, Nicolson GL: Human peritumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell trains. Int J Cancer 62: 585–592, 1995

    Google Scholar 

  4. Sakakura T: New aspects of stroma-parenchyma relations in mammary gland differentiation. Int Rev Cytol 125: 165–202, 1991

    Google Scholar 

  5. Birchmeier C, Birchmeier W: Molecular aspects of mesenchymal-epithelial interactions. Ann Rev Cell Biol, 9: 511–540, 1993

    Google Scholar 

  6. van den Hoff A: Stromal involvement in malignant growth. Adv Cancer Res 50: 159–196, 1998

    Google Scholar 

  7. Nakamura T, Nawa K, Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochem Biophys Res Commun 122: 1450–1459, 1984

    Google Scholar 

  8. Stoker M, Perryman M: An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 77: 209–223, 1985

    Google Scholar 

  9. Jiang WG, Hiscox S, Matsumoto K, Nakamura T: Hepatocyte growth factor/scatter factor, its moleculr, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29: 209–248, 1999

    Google Scholar 

  10. Corps AN, Sowter HM, Smith SK: Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met. Int J Cancer 73: 151–155, 1997

    Google Scholar 

  11. Hiscox S, Jiang WG: Hepatocyte growth factor/scatter factor disrupts epithelial tumour cell-cell adhesion: involvement of b-catenin. Anticancer Res 19: 509–518, 1999

    Google Scholar 

  12. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G: Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 94: 701–706, 1997

    Google Scholar 

  13. Laterra J, Nam M, Rosen E: Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest 76: 565–577, 1997

    Google Scholar 

  14. Date K, Matsumoto K, Shimura H, Tanaka M, Nakamura T: HGF/NK4 is a specific antagonist for pleiotropic actions of hepatocyte growth factor. FEBS Lett 420: 1–6, 1997

    Google Scholar 

  15. Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T: Inhibition of tumour growth and invasion by fourkringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 17: 3045–3054, 1998

    Google Scholar 

  16. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245, 1987

    Google Scholar 

  17. Parish CR, Jakobsen KB, Coombe DR: A basement membrane permeability assay which correlates with the metastatic potential of tumor cells. Int J Cancer 52: 378–383, 1992

    Google Scholar 

  18. Hoppe A, Jiang WG, Wertheim D, Williams R, Harding K: A system for computer analysis of cancer cell movement. Anticancer Res 18: 2691–2694, 1998

    Google Scholar 

  19. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE, Puntis MCA: Regulation of the expression E-cadherin on human cancer cells by gamma linolenic acid (GLA). Cancer Res 55: 5043–5048, 1995

    Google Scholar 

  20. Nakamura T, Nishizawa T, Hagiya M: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443, 1989

    Google Scholar 

  21. Nakamura T: Structure and function of hepatocyte growth factor. Prog Growth Factor Res 3: 67–85, 1991

    Google Scholar 

  22. Hasegawa Y, Yamamoto M, Maeda S, Saitoh Y: Hepatocyte growth-factor and its receptor c-met regulate both cell-growth and invasion of human pancreatic-cancer. Int J Oncology 7: 877–881, 1995

    Google Scholar 

  23. Jiang WG, Lloyd D, Puntis MCA, Hallett MB: Regulation of spreading and growth of human colon cancer cells by hepatocyte growth factor. Clin Exp Metastasis 11: 235–242, 1993

    Google Scholar 

  24. Matsumoto K, Date K, Shimura H, Nakamura T: Acquisition of invasive phenotype in gallbladder cancer-cells via mutual interaction of stromal fibroblasts and cancer-cells as mediated by hepatocyte growth-factor. Jpn J Cancer Res 87: 702–710, 1996

    Google Scholar 

  25. Rosen EM, Goldberg ID, Jaken S, Grant DS: Regulation of endothelial-cell migration and capillary-like tube formation by scatter factor. Circulation 82: 699, 1990

    Google Scholar 

  26. VanBelle E, Witzenbichler B, Chen DH: Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor – the case for paracrine amplification of angiogenesis. Circulation 97: 381–390, 1998

    Google Scholar 

  27. Grant DS, Kleinman HK, Goldberg ID: Scatter factor induces blood-vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937–1941, 1993

    Google Scholar 

  28. Matsumoto K, Nakamura T: Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239: 639–644, 1997

    Google Scholar 

  29. Yamamoto S, Wakimoto H, Aoyagi M: Modulation of motility and proliferation of glioma cells by hepatocyte growth factor. Jpn J Cancer Res 88: 564–577, 1997

    Google Scholar 

  30. Inoue T, Chung YS, Yashiro M: Transforming growth factorbeta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res 88: 152–159, 1997

    Google Scholar 

  31. Jeffers M, Rong S, Anver M, Vandewoude GF: Autocrine hepatocyte growth-factor scatter factor-met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene 13: 853–861, 1996

    Google Scholar 

  32. Jiang WG, Hiscox S, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE: Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clin Cancer Res 5: 3695–3703, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hiscox, S., Parr, C., Nakamura, T. et al. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4. Breast Cancer Res Treat 59, 245–254 (2000). https://doi.org/10.1023/A:1006348317841

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006348317841

Navigation